Purpose: The aim of this study was to evaluate by lymphoscintigraphy the functional outcome after autologous lymph vessel transplantation (Tx) of the upper limb. Methods: One hundred seventy-seven patients (172 female, 5 male; median age, 56 years; range, 12-84 years) presenting with Tx situs in an upper limb were included. For correlation of scintigraphic data versus reduction of volume (RV) surplus measurements, we examined at 4 different time points as follows: preoperatively (T 0 ), within 2 weeks after Tx (T 1 ), 6 to 12 months after Tx (T 2 ), and 32 to 38 months after Tx (T 3 ). An additional long-term follow-up after at least 8 years (T 4 ) was available in some cases. Results: The maximum individual postoperative observation period was 19 years. In 169 of 177 cases, lymphedema had been caused by treatment of breast cancer (mastectomy, n = 103/169; breast preserving, n = 66/169) and/or radiation therapy (n = 130/177), but 2 patients presented with primary lymphedema. The remaining 6 cases of lymphatic disorders were caused by treatment of malignant melanoma, Hodgkin lymphoma, axillary Ewing sarcoma, non-Hodgkin lymphoma, hemangioma, or abscess removal.
L ymphedema of the upper limb arises as a frequent sequelus after lymphonodectomy, primarily due to surgical treatment of breast cancer. The condition of lymphedema is characterized by excess tissue protein, edema, chronic inflammation, and fibrosis. Usually, the diagnosis is based on clinical findings, but imaging studies permit objective confirmation of the extent of lymphatic dysfunction. 1, 2 In general, diagnostic imaging of lymphatic function is obtained directly by means of lymphoscintigraphy or by indocyanine green lymphography, whereas secondary morphological disorders such as edema in fat tissue is detected by MRI, and the presence of fibrotic tissue is determined by CT. 3 In particular, lymphoscintigraphy serves to monitor noninvasively the outcome of microsurgical interventions to restore lymph drainage, through the procedure of autologous lymph vessel transplantation (Tx). To this end, we have previously established and validated an objective scintigraphic assessment of lymphatic function. 4, 5 The aim of the present study was to characterize by visual and semiquantitative criteria lymph kinetics of the upper limb in patients after microsurgical treatment with autologous vessel transplantation.
PATIENTS AND METHODS

Patient Selection and Demographics
One hundred seventy-seven of 209 (172 females, 5 males) consecutive patients seen at the clinic during 1981 to 2010 for Tx in the upper limb were included in our retrospective study, with these exclusions as follows: in 1 patient, volume measurements of the affected limb could not be performed due to dysmelia, whereas in 31 of 209 patients, scintigraphic records were incomplete or improperly archived. The mean patients' age at date of inclusion was 54.6 years (range, 12.0-83.9 years; Table 1 ).
Transplantation
All patients gave written informed consent before autologous lymph vessel transplantation. Lymphatic grafts were taken from the ventromedial lymphatic bundle from the patients' thighs. After placement within a subcutaneous tunnel, these vessel grafts were anastomosed with major collecting lymph vessels at the upper arm and lymphatics in the neck region ( Fig. 1A ). Thus, recirculation was restored within the lymphatic system, avoiding problems that can arise due to differing pressures between the venous and the lymphatic system. 6, 7 Volume Measurement Pretherapeutic and posttherapeutic volume measurements of the upper extremities were calculated by the cylinder method described by Kuhnke. 8 Whenever feasible, the limb girth measurements were performed with consistent tension and at the same time of day. Equal limb position and the uppermost measurement site (axilla) were maintained in each patient. The total limb volume was calculated as the sum of the individual segment volumes (intersegment lengths 4-5 cm). For this model, the segmental volume (V) in relation to the measured circumferences (C i ) is given by the formula V = (C 1 2 + C 2 2 +… C n 2 )/π ( Fig. 2) . A total of 738 arm volume measurements were performed with a mean of 4 per patient and a maximum of 23 (Table 1) .
Scintigraphic Investigation
A total of 546 lymphoscintigraphies of the affected limb were performed, with a mean of 3 per patient and a maximum of 13. The preoperative and postoperative administered dose of the 99m Tc-labelled human serum albumin (volume, 0.3-1.0 mL) was in the range 76 to 84 MBq (T 0 -T 4 ). The radiopharmaceutical was administered by injection from 27-gauge needles inserted in subcutaneous tissue of the first interdigital space of the affected hand, thus strictly avoiding intravascular application. Because lymphatic flow in resting extremities is fairly poor, all patients were asked to stimulate lymphatic drainage by active muscular exercise (10 minutes by opening and closing the fist), beginning immediately after radiopharmaceutical injection.
We obtained sequential emission images of the affected limb using a large FOV γ-camera fitted with a low-energy, high-resolution collimator (Fig. 1C-E ). For semiquantitative evaluation of lymphatic drainage, a numeric transport index (TI) was used. In assessing this TI, 5 visually assessed criteria were evaluated, these are the following: (1) lymphatic transport kinetics, (2) distribution pattern of the radiopharmaceutical, (3) time to appearance of lymph nodes, (4) visualization of lymph nodes, and (5) visualization of lymph vessels/grafts. According to these parameters ( Table 2) , lymphatic flow was normal if no substantial delay of lymphatic transport kinetics was observed, if the distribution pattern was not diffuse, if the time of appearance of the lymph nodes was less than 25 minutes after injection, and when lymph nodes and vessels were clearly visible. Thus, the resulting TI (9 points per criterion) ranged from 0 (normal) to 45 (pathological), where any TI less than 10 in healthy extremities is considered normal. 4, 5 
Image Analysis
The data sets of lymphoscintigraphic tests were analyzed in consensus by 2 nuclear medicine physicians, both with at least 20 years of experience. For correlation of scintigraphic data versus clinical volume measurements, 4 different time points (T 0-4 ) were determined for all included patients; these are as follows: preoperatively (T 0 ), within 2 weeks after Tx (T 1 ), 6 to 12 months after Tx (T 2 ), and 32 to 38 months after Tx (T 3 ). An additional long-term follow-up was performed in 19 cases at least 8 years after treatment (T 4 ). A maximum time gap of 6 months between scintigraphic tests and volume measurements was set to permit a valid correlational analysis.
Statistical Evaluation
Data were expressed as the mean (SD), and differences in the mean between preoperative and postoperative findings were assessed using the paired 2-tailed Student t test. A probability value of P < 0.05 was regarded as significant.
RESULTS
In 169 (95%) of 177 cases, lymphedema was caused by treatment of breast cancer (mastectomy for 103 of 169 and breast preserving for 66 of 169 such cases). Furthermore, there were 2 patients presenting with primary lymphedema; in 6 of 177 cases, the lymphatic disorders were provoked by treatment either of malignant melanoma, Hodgkin lymphoma, axillary Ewing sarcoma, non-Hodgkin lymphoma, hemangioma, or abscess removal. A total of 130 (73%) of 177 patients received adjuvant radiation therapy of the affected hemithorax before lymphedema of the affected arm (Table 1) . No postoperative rejections occurred in this series of autologous lymphatic vessel transplants.
In 26 (15%) of 177 cases, there was additional treatment by lipolymphosuction; in these patients, only scintigraphic data and the respective volume measurements before lipolymphosuction were included in the analysis.
Volume Measurement
Volume estimation based on tape measurements of circumference of the affected arm was performed in all patients either on the day before or on the same day of microsurgical transplantation (T 0 ). Postoperatively, patients underwent volume measurements during hospitalization within the first 2 weeks after transplantation (T 1 ) and additionally at a mean of 8.1 months (T 2 ) and 32 
Lymphoscintigraphy
All patients underwent a preoperative scintigraphic baseline study (T 0 ) and at least 1 scintigraphic follow-up after microsurgical Tx treatment, either during hospitalization within the first 2 weeks postsurgically (T 1 ) or at a mean of 8.2 months (T 2 ) and 36.6 months (T 3 ); additional long-term follow-up in 19 patients was performed at a mean of 14.1 years (T 4 ). Table 3 presents the time of the performance of volume measurements and scintigraphic tests in relation to the day of autologous lymph vessel transplantation. For correlation, the time intervals for T 0-4 fell below the default of a maximum 6-month gap between the date of volume measurements and the respective scintigraphic acquisitions.
Correlation
As presented in Figure 3 , at T 1 , the mean volume reduction (RV) of the affected limb was 73.2%, and the mean improvement of the TI was 27.9%. At T 2 , the mean RV was 63.7%, and the TI was 23.4%, whereas at T 3 , the mean RV was 62.8%, and the TI was 24.9%. In the subgroup of patients (19/177) presenting with clinical and scintigraphic long-term follow-up, periods extended to more than 8 years (T 4 : mean, 14.1 years; range, 9-19.2 years). Persistent improvements of the scintigraphic data (25.2% decrease in TI) were confirmed by the concomitant 68.4% clinical RV. Overall, the clinical RVs and scintigraphic improvements of lymph kinetics were related by a mean factor of 2.64 (median, 2.67).
DISCUSSION
Promising results have been reported for magnetic resonance (MR) lymphangiography as a complementary modality for imaging of the peripheral lymphatic system of the lower limb. 9 However, this modality remains for technical reasons unsuited for investigation of the upper extremities. Furthermore, an important constraint of MR lymphangiography arises from the present requirement for off-label intracutaneous injection of gadolinium chelates. As an alternative to MR, radiologic lymphography with oily contrast agents is contraindicated in lymphedema, as it may cause lymphadenitis, with resultant Lymphedema of the Upper Limb exacerbation of existing edema. 1, 10 There have been some very preliminary reports on indocyanine green lymphography for the diagnosis of upper extremity lymphedema. 11, 12 Among the most important parameters for diagnosis of lymphedema are the occurrence of dermal backflow of lymph, as can occur in abnormal lymph vessels, and also the asymmetry of axillary lymph nodes. Given the importance of detecting these factors, lymphoscintigraphy remains the preferred diagnostic method to assess functional lymphatic disorders of the upper limb. 13, 14 Only a single subcutaneous tracer injection in the affected extremity is required; the scintigraphy procedure is technically easy to perform, causing minimal discomfort, and is generally without adverse effects for patients. 15 Lymphoscintigraphy provides information about lymph transport, filtration, and reticuloendothelial function. The lymphoscintigraphic transport kinetics of 99m Tc-bound agents substantially depends on their particle size; for reliable transport from the interstitium to initial lymph vessels and for adequate lymph node uptake of tracers, an optimal particle size of about 80 to 100 nm has been suggested, 16, 17 which matches the size of albumin particles used in the present study. From the inception of this project in 1981, the standardized scintigraphic tests and the technique of the clinical volume measurements used in our patient population have been maintained essentially without change. In particular, we have adhered to a fixed standard for the injected radiopharmaceutical dose and volume. For the clinical measurements of circumferences, the number of segments included in the volume calculation necessarily depends on intersegment lengths; smaller intersegment lengths have been reported to provide better resolution. [18] [19] [20] [21] [22] [23] [24] [25] Visual interpretation of scintigraphic images is particularly helpful in determining the characteristics of lymphedema and is thus of clinical importance in planning microsurgical procedures. 16, 26 A semiquantitative index of lymphatic transport in addition to visual evaluation of the lymphoscintigraphic image pattern more reliably depicts abnormalities of the lymphatic circulation. 4, 5, 13 Consequently, visual and semiquantitative interpretation of scintigraphic data can verify the outcome of this sophisticated microsurgical technique. Present results attest to this benefit even in long-term follow-up, wherein persistent restoration of function by lymphatic vessel grafts is also demonstrated by the persistently reduced values of the semiquantitative TI. The comparison of preoperative versus postoperative changes of the calculated TIs confirmed the clinically observed postoperative RVs of the affected extremities after lymph vessel transplantation. After the microsurgical grafting treatment, our patients showed the most extensive RV (73%) and improvement of scintigraphic data (28%) within the first 2 weeks after transplantation. It must be conceded that this acute benefit is derived in part from consistent elevation of the affected arm throughout hospitalization. In the longer term, we observed a mean RVof 63% after lymph vessel transplantation, attaining 68% a decade after surgery. There was a strong correlation between clinical versus scintigraphic improvements, which were related by a constant factor of 2.64. The follow-up studies demonstrate the persisting success of microsurgical treatment, whereby clinical improvement is linked to improved drainage of the radiopharmaceutical and a constant decrease in the TI compared with preoperative findings, lasting at least a decade.
Although the autologous lymphatic vessel grafts evidently bridged local gaps in the lymphatic system of the affected limb, the TI did not in all cases decline to values within the reference range. If we consider that the grafted lymphatic system consists of a system of drainage channels bypassing a lymphatic transport stoppage, a more reliable and complete restoration of function might have been expected. However, in chronic lymphedema, there is disturbance not only in the lymphatic vessels, but also in the surrounding and functionally associated connective tissue. Despite the scintigraphically demonstrated improvement of dynamic flow within the lymphatic collectors, the secondary changes (fibrosis, sclerosis, increase in adipose tissue) may not be resolved or restored to the same extent in each patient; this According to these parameters, lymphatic flow was normal if no substantial delay of lymphatic transport kinetics was observed, the distribution pattern was not diffuse, the time of appearance of the lymph nodes was less than 25 minutes after injection, and lymph nodes and vessels were clearly visible. Thus, the resulting TI ranged from 0 (normal) to 45 (pathological), where any TI less than 10 in healthy extremities is considered normal. p.i. indicates post injection. limitation might clarify why in some cases the postoperative improvements in RV persist at some suboptimal level despite the visually manifested scintigraphic improvements. We suppose that better results could be obtained through earlier microsurgical treatment because patients referred earlier usually have less lymphatic interruptions and fibrotic tissue. 5, [27] [28] [29] Despite discrepancies in some patients, the stability of restored lymphatic function, which was documented up to 19 years after surgery, indicates that the Tx microsurgical technique has a valuable role in the treatment of lymphedema. In the group of patients with clinical and scintigraphic long-term follow-up periods of at least 8 years, we observed a persistent 25% decrease in TI, in conjunction with a mean 68% reduction in volume surplus, thus confirming the lasting and even progressive benefit of Tx and also the utility of functional imaging by means of lymphoscintigraphy.
There are a few limitations of our study to discuss. First, it can be assumed that quantifying by region of interest (ROI) analysis of the lymph node uptake might well have provided greater clinically relevant information than is afforded by our approach of visual interpretation combined with a semiquantitative TI. However, earlier clinical results have proven that lymphoscintigraphy combined with our convenient semiquantitative evaluation of the numeric TI correlates well with clinical findings. 4, 5 Furthermore, qualitative and quantitative lymphoscintigraphic results often prove to be concordant, especially when clinical signs of lymphedema are more pronounced. The qualitative lymphoscintigraphy provides information about the physiology of lymphatic disorders, such as delay of transport, rarefication or missing visualization of regional lymph nodes, and the presence of "dermal backflow"; it also provides direct visualization of lymphatic channels and collateral lymphatic channels. Although a more quantitative ROI measurement of lymph node uptake is possible in principle, this would require applying standardized procedures that are necessarily more complex and time-consuming in daily clinical routine. We also note that our use of standardized muscular exercise of the injection site may introduce variability in lymph flow and local differences in lymphatic drainage from the tracer injection site. In addition, partial removal of the radiopharmaceutical by the venous circulation may also complicate quantitative ROI interpretation. Indeed, the initial extent of uptake of particulate imaging agents into lymph must depend on the anatomic injection site and the injected volume of the radiopharmaceutical. Therefore, we suppose that quantitative ROI studies would provide little additional information of clinical relevance and without great benefit for the baseline diagnosis of lymphedema or in the selection of patients eligible for transplantation. [30] [31] [32] [33] [34] [35] [36] [37] [38] An additional limitation of this retrospective study is that we cannot conclude that additional use of the SPECT/CT technique would have improved upon the diagnostic value of planar lymphoscintigraphy. SPECT/CT was only recently implemented in our department and has not yet found routine use in assessing lymphatic function. However, we expect that SPECT/CT will yield improved anatomical correlation of lymphatic transport disorders and thus allow better assessment of the extent of pathology; in addition, tomographic acquisition by SPECT/CT should reduce image-degrading effects of partial volume for small vessels. 39 Finally, we note that assessments of the lymphoscintigraphic examinations were performed by consensus, such that interreader correlation cannot be established in our retrospective study. However, consensus reading by 2 experienced nuclear medicine physicians is in our hands a reliable and efficient method to obtain the clinically relevant information.
CONCLUSIONS
To our knowledge, this scintigraphy study entails the largest series of patients undergoing autologous lymph vessel transplantation at the upper limb. Our findings confirm that this microsurgical technique significantly improved lymph drainage in patients with lymphedema of the arm. We find that lymphoscintigraphy is an easily performed and reliable method to assess lymph kinetics before and after autologous lymph vessel transplantation. This diagnostic technique is safe and imparts no risk of further compromising vascular drainage. The findings of lymphoscintigraphy closely match the volume measurements with long-term follow-up. We conclude that interpretation of scintigraphic data is not only helpful in baseline diagnosis and planning microsurgical treatment, but also in monitoring the postoperative outcome and long-term follow-up of lymphatic function.
